ABL1 and leukemia: Philadelphia chromosome positive (Ph+) leukemia is a malignant clonal disease derived from hematopoietic stem cells, which is characterized by the expression of BCR-ABL fusion protein possessing strong tyrosine kinase activity [1, 2].